Non-AIDS-associated Kaposi's sarcoma (classical and endemic African types): treatment with low doses of recombinant interferon-alpha.

@article{Rybojad1990NonAIDSassociatedKS,
  title={Non-AIDS-associated Kaposi's sarcoma (classical and endemic African types): treatment with low doses of recombinant interferon-alpha.},
  author={Michel Rybojad and Luca Borradori and Olivier V{\'e}rola and Jacques Zeller and Anne Puissant and Patrice Morel},
  journal={The Journal of investigative dermatology},
  year={1990},
  volume={95 6 Suppl},
  pages={176S-179S}
}
In the treatment of the classical and endemic African forms of Kaposi's sarcoma (KS), radiation therapy and chemotherapy have been widely used with varying degrees of success and morbidity. We here report our preliminary experiences with low doses of recombinant interferon alfa-2b (rIFN alpha-2b) in the treatment of these types of KS, non-linked to the acquired immunodeficiency syndrome (AIDS). Ten consecutive patients (eight patients with classical and two with endemic KS) with a median age of… CONTINUE READING